Japan oral anti-diabetic drug market size is projected to exhibit a growth rate (CAGR) of 4.33% during 2024-2032. The rising prevalence of diabetes, due to factors like changing lifestyles and the increasing obesity rates, is primarily driving the market growth. https://www.imarcgroup.com/japan-oral-anti-diabetic-drug-market